🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To provide elotuzumab treatment for single-patient use....
Status
No Longer Available
Location
Icahn School.of Medicine at Mount Sinai
Start Date
TBD
Trial ID
NCT02541643
Treatments Being Tested
The purpose of this study is to determine the efficacy of Lenalidomide/Dexa...
Status
Completed
Location
Local Institution
Start Date
2015-02-20
Trial ID
NCT02272803
Treatments Being Tested
The Total Therapy treatment regimens developed at the Myeloma Institute hav...
Status
Withdrawn
Location
University of Arkansas for Medical Sciences
Start Date
2017-10-01
Trial ID
NCT03168100
Treatments Being Tested
To assess the safety and tolerability, characterize the dose limiting toxic...
Status
Completed
Location
University Of Arkansas For Medical Sciences
Start Date
2014-12-09
Trial ID
NCT02252263
Treatments Being Tested
The food and drug administration (FDA) has approved the use of Selinexor, a...
Status
Withdrawn
Location
Multiple Locations
Start Date
2022-04-27
Trial ID
NCT05170789
Treatments Being Tested
BMS will conduct a regulatory postmarketing surveillance (PMS) to evaluate ...
Status
Completed
Location
Local Institution
Start Date
2018-01-01
Trial ID
NCT02976493
Treatments Being Tested
This research study is studying a combination of targeted therapies as a po...
Status
Withdrawn
Location
Massachusetts General Hospital
Start Date
2018-12
Trial ID
NCT03227432
Treatments Being Tested
The purpose of this clinical trial is to examine the role of an immune modu...
Status
Withdrawn
Location
Multiple Locations
Start Date
2021-04
Trial ID
NCT04584307
Treatments Being Tested
This is a multicenter, randomized, open-label, Phase 3 study comparing the ...
Status
Completed
Location
Local Institution - 109
Start Date
2019-04-16
Trial ID
NCT03651128
This study was a multi-center, open-label, single-arm, Phase 2 study where ...
Status
Completed
Location
University of Chicago
Start Date
2017-07-10
Trial ID
NCT02969837
Treatments Being Tested